9 results
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Receptor, Heart Rate/Inotropy ... #Pharmacology #Effect ... #Management #Comparison ... #Inotropes
Common Vasopressors and Inotropes
Norepinephrine (NE)
 - Indication: Distributive shock (1st line for septic shock), Cardiogenic shock
Vasopressors and Inotropes ... is not desired (e.g ... #Vasopressors #Inotropes ... #comparison #table ... #pharmacology #criticalcare
Vasopressors and Inotropes
 • Norepinephrine - Levophed - "Levo" - Generally thought of as the first
Vasopressors and Inotropes ... of shock, HOCM, etc ... #management #criticalcare ... #summary #comparison ... #table #pharmacology
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
Disease, Mechanical Defect ... rupture, VSD, etc ... Arrhythmias / CHB ... inopressors #diagnosis #management ... #comparison #table
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
weaknesses, and adverse effects ... Hepatotoxicity, QTc ... hypokalemia, negative inotrope ... #valleyfever #management ... #comparison #table
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
decompensated CHF ... a synergistic effect ... #Medications #management ... #treatment #comparison ... #table
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
ECG is vital while ... patients need inotrope ... #table #foamed ... #heartfailure #chf ... #criticalcare #
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
in the treatment ... Hepatotoxicity, QTc ... hypokalemia, negative inotrope ... #pharmacology #management ... #treatment #coccidioides
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
May have typical HF ... Management during ... Delivery • Stable ... therapy, including inotropes ... #cardiology #treatment